|
Targeted therapy of pancreatic cancer with in vivo radionuclide generator
|
5R21CA156088-02
|
$216,630
|
$216,630
|
DADACHOVA, EKATERINA
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Core Support for Cancer Center
|
3P30CA013330-39S4
|
$3,757,417
|
$150,297
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Core Support for Cancer Center
|
3P30CA013330-39S5
|
$249,999
|
$10,000
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Core Support for Cancer Center
|
3P30CA013330-39S6
|
$249,999
|
$10,000
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Core Support for Cancer Center
|
3P30CA013330-39S7
|
$75,000
|
$3,000
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Deciphering the Tissue Specificity of MEN1 Related Tumorigenesis
|
1R01CA170911-01
|
$346,525
|
$173,263
|
Libutti, Steven
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Interactions of the angiopoietin and PD-ECGF pathways in tumor angiogenesis
|
1R01CA163907-01A1
|
$364,002
|
$364,002
|
SCHWARTZ, EDWARD
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
A Major Nutritional Effect on Intestinal Stem Cells and Tumors
|
1R01CA214625-01A1
|
$294,022
|
|
AUGENLICHT, LEONARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
(7) Novel imaging devices for measurement and control of tumor microenvironments
|
5R01CA216248-02
|
$607,904
|
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Einstein-Rockefeller-CUNY Center for AIDS Research
|
5P30AI124414-02
|
$174,258
|
|
GOLDSTEIN, HARRIS
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
B7x in Cancer: Mechanisms and Therapies
|
1F30CA224931-01
|
$49,524
|
|
JOHN, PETER
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Paul Calabresi Career Development Award for Clinical Oncology (K12)
|
5K12CA132783-10
|
$508,802
|
|
PEREZ-SOLER, ROMAN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Investigating the role of Nol3 in normal and malignant hematopoiesis
|
1F30CA217063-01A1
|
$49,524
|
|
PISZCZATOWSKI, RICHARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Methylthioadenosine Phosphorylase and AdoMet Synthetase in Cancer
|
5R01CA135405-11
|
$290,592
|
|
SCHRAMM, VERN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Mechanisms of Formation and Progression of Preleukemic Stem Cells
|
5R01CA217092-02
|
$397,371
|
|
STEIDL, ULRICH
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
The B7x pathway in the tumor microenvironment
|
5R01CA175495-06
|
$346,525
|
$69,305
|
ZANG, XINGXING
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Community Clinical Oncology Program
|
5U10CA037422-25
|
$4,499,349
|
$89,987
|
BRUNER, DEBORAH
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Radiation Therapy Oncology Group
|
3U10CA021661-36S1
|
$172,284
|
$6,891
|
Curran, Walter
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Radiation Therapy Oncology Group
|
5U10CA021661-36
|
$12,915,055
|
$516,602
|
Curran, Walter
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
RTOG Biospecimen Repository
|
5U24CA114734-07
|
$500,745
|
$50,075
|
Curran, Walter
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Imaging and Radiation Oncology Core (IROC) Group
|
5U24CA180803-05
|
$8,285,739
|
|
FOLLOWILL, DAVID
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Mutation-Specific p53 Antibodies as Biomarkers of Pancreatic Cancer
|
1R21CA164593-01
|
$212,556
|
$212,556
|
ANDERSON, KAREN
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Rapid Point of Care Detection of HPV-Associated Malignancies
|
5UG3CA211415-02
|
$338,933
|
|
ANDERSON, KAREN
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Effects of Meditative Movement (Qigong/Tai Chi Easy) on Fatigued Breast Cancer Survivors
|
5R01CA182901-04
|
$612,939
|
|
LARKEY, LINDA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Arizona Cancer and Evolution Center (ACE)
|
1U54CA217376-01A1
|
$1,906,167
|
|
MALEY, CARLO
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
IDO-Expressing Immunoregulatory Dendritic Cells
|
5R01CA103320-15
|
$307,800
|
|
MUNN, DAVID
|
AUGUSTA UNIVERSITY
|
|
Chemotherapy-induced MDSCs and antitumor immunity
|
5R01CA215523-02
|
$347,700
|
|
ZHOU, GANG
|
AUGUSTA UNIVERSITY
|
|
Development of cell-free DNA assays for HCC screening and liquid biopsy
|
5R01CA202769-03
|
$397,877
|
|
SU, YING-HSIU
|
BARUCH S. BLUMBERG INSTITUTE
|
|
An ultrasensitive targeted mass spectrometry system for proteomics analysis of single cells
|
1R21CA223715-01
|
$263,953
|
|
SHI, TUJIN
|
BATTELLE PACIFIC NORTHWEST LABORATORIES
|
|
Pediatric Oncology Clinical Research Training Program
|
5K12CA090433-17
|
$827,164
|
|
BLANEY, SUSAN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Discovery, Biology and Risk of Inherited Variants in Glioma
|
1R01CA217105-01A1
|
$1,043,807
|
|
BONDY, MELISSA
|
BAYLOR COLLEGE OF MEDICINE
|
|
MECHANISMS OF AR-ER COLLABORATION IN HORMONE RESISTANCE AND METASTASIS OF BREAST CANCER
|
5R01CA207270-02
|
$362,569
|
|
FUQUA, SUZANNE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Mechanisms of KLF4 suppression in pediatric leukemia
|
5R01CA207086-02
|
$370,641
|
|
LACORAZZA, DANIEL
|
BAYLOR COLLEGE OF MEDICINE
|
|
Identifying and targeting oncogenic Myc enhancer control in pediatric tumors
|
5R01CA215452-02
|
$362,569
|
|
LIN, CHARLES
|
BAYLOR COLLEGE OF MEDICINE
|
|
Metabolic Regulation in Leukemia-Initatiating Cells
|
5R01CA193235-04
|
$462,191
|
|
NAKADA, DAISUKE
|
BAYLOR COLLEGE OF MEDICINE
|
|
DEFINING THE ROLE OF DOT1L IN DNMT3A-MUTANT LEUKEMIA
|
5K08CA201611-02
|
$162,148
|
|
RAU, RACHEL
|
BAYLOR COLLEGE OF MEDICINE
|
|
De facto Target of Histone Deacetylase Inhibitors
|
5R21CA215591-02
|
$172,369
|
|
SUN, ZHENG
|
BAYLOR COLLEGE OF MEDICINE
|
|
Drugging the Undruggable Coactivators using Small Molecule Inhibitors
|
5R01CA207701-02
|
$426,451
|
|
WANG, JIN
|
BAYLOR COLLEGE OF MEDICINE
|
|
METHYLATION BIOMARKER DEVELOPMENT FOR NONINVASIVE DETECTION OF COLORECTAL CANCER
|
5R01CA181572-05
|
$319,735
|
|
GOEL, AJAY
|
BAYLOR RESEARCH INSTITUTE
|
|
Role of Receptor for Advanced Glycation End Product (RAGE) Pathway in Brain Tumors
|
5R01CA155769-07
|
$410,877
|
|
BADIE, BEHNAM
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
The role and functional mechanism of TET1 in MLL-rearranged leukemia
|
5R01CA178454-07
|
$369,725
|
|
CHEN, JIANJUN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
The role and mechanism of FTO in leukemogenesis and drug response
|
5R01CA214965-03
|
$444,571
|
|
CHEN, JIANJUN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
A novel VLP vaccine to prevent EBV infection and EBV - associated malignancies
|
5R21CA205106-02
|
$176,605
|
|
OGEMBO, JAVIER
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Development and validation of a computational prediction model for exogenous neural stem cell migration to sites of brain tumors
|
1R03CA216142-01A1
|
$86,500
|
|
ROCKNE, RUSSELL
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Novel RNA-Directed Therapy for the Treatment of Acute Myeloid Leukemia
|
5R01CA201496-03
|
$479,954
|
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Regulation of Single Strand Annealing Repair of Mammalian Chromosomal Breaks
|
5R01CA197506-03
|
$388,875
|
|
STARK, JEREMY
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
A Multimedia Self-Management Intervention to Prepare Family Caregivers and Patients for Lung Cancer Surgery
|
1R01CA217841-01A1
|
$717,367
|
|
SUN, VIRGINIA
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Molecular Mechanisms of BRCA1-Dependent DNA Damage Response and Tumorogenesis
|
5R01CA132755-11
|
$382,500
|
$126,225
|
YU, XIAOCHUN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Control of tumor growth and metastasis by the cytokine TSLP
|
5R01CA182783-05
|
$362,503
|
|
ZIEGLER, STEVEN
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Humanized Anti-Renalase Antibodies for Unresectable Melanoma
|
1R43CA224463-01
|
$299,996
|
|
BERKOWITZ, BARRY
|
BESSOR PHARMA, LLC
|
Total relevant funding to Pancreas for this search: $141,890,923
|